Kiniksa Pharmaceuticals International, plc (KNSA) › Capital ExpendituresKiniksa Pharmaceuticals International, plc (KNSA) — Capital ExpendituresAnnual figures by period end, from SEC filings.2017-12-31: $69.0K2018-12-31: $5.29M2019-12-31: $3.20M2020-12-31: $283.0K2021-12-31: $415.0K2022-12-31: $105.0K2023-12-31: $130.0K2024-12-31: $277.0K2025-12-31: $1.57M$1.57M2017-12-31Capital Expenditures (USD)2025-12-31Period endedCapital ExpendituresChange YoYSource filing2025-12-31$1.57M+466.1%2026-02-24From 2025-01-012024-12-31$277.0K+113.1%2026-02-24From 2024-01-012023-12-31$130.0K+23.8%2026-02-24From 2023-01-012022-12-31$105.0K-74.7%2025-02-25From 2022-01-012021-12-31$415.0K+46.6%2024-02-28From 2021-01-012020-12-31$283.0K-91.2%2023-03-02From 2020-01-012019-12-31$3.20M-39.5%2022-02-24From 2019-01-012018-12-31$5.29M+7566.7%2021-02-25From 2018-01-012017-12-31$69.0K—2019-03-12From 2017-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)